CQS
GSK icon

Credential Qtrade Securities’s GSK GSK Stock Holding History

Credential Qtrade Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$359K Sell
8,369
-30
-0.4% -$1.24K 0.02% 217
2023
Q4 		$311K Sell
8,399
-273
-3% -$9.8K 0.02% 199
2023
Q3 		$314K Sell
8,672
-375
-4% -$13.3K 0.02% 197
2023
Q2 		$322K Sell
9,047
-1,134
-11% -$40.7K 0.02% 205
2023
Q1 		$362K Buy
10,181
+238
+2% +$8.33K 0.02% 204
2022
Q4 		$349K Sell
9,943
-496
-5% -$16.5K 0.03% 207
2022
Q3 		$307K Buy
10,439
+5,368
+106% +$203K 0.02% 194
2022
Q2 		$276K Buy
5,071
+213
+4% +$11.8K 0.02% 208
2022
Q1 		$265K Sell
4,858
-18,300
-79% -$994K 0.02% 228
2021
Q4 		$1.28M Buy
23,158
+1,972
+9% +$103K 0.09% 109
2021
Q3 		$1.01M Buy
21,186
+2,241
+12% +$113K 0.08% 119
2021
Q2 		$943K Buy
18,945
+4,256
+29% +$204K 0.07% 121
2021
Q1 		$655K Buy
14,689
+10,223
+229% +$464K 0.06% 134
2020
Q4 		$205K Sell
4,466
-244
-5% -$11.2K 0.02% 203
2020
Q3 		$222K Sell
4,710
-172
-4% -$8.62K 0.03% 186
2020
Q2 		$249K Sell
4,882
-46
-0.9% -$2.36K 0.03% 162
2020
Q1 		$233K Sell
4,928
-141
-3% -$7.52K 0.04% 146
2019
Q4 		$298K Sell
5,069
-3,163
-38% -$176K 0.04% 144
2019
Q3 		$439K Buy
8,232
+7
+0.1% +$360 0.07% 124
2019
Q2 		$411K Buy
8,225
+262
+3% +$13.1K 0.07% 126
2019
Q1 		$416K Sell
7,963
-196
-2% -$9.79K 0.08% 126
2018
Q4 		$390K Buy
8,159
+3,293
+68% +$162K 0.09% 121
2018
Q3 		$244K Buy
+4,866
New +$247K 0.05% 155

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credential Qtrade Securities's GSK Position: Q1 2024 in Review

Credential Qtrade Securities reduced its GSK (GSK) stake by 0.36% in Q1 2024, selling an estimated $1.24K and leaving 8,369 shares worth $359K. The position accounts for 0.02% of the portfolio, ranked #217.

Credential Qtrade Securities first reported a position in GSK in Q3 2018 and has held it in 23 quarters since. The position peaked at $1.28M in Q4 2021. 911 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Credential Qtrade Securities held 8,369 shares of GSK worth $359K as of Q1 2024.
  • Credential Qtrade Securities sold 30 GSK shares in Q1 2024, an estimated $1.24K.
  • GSK made up 0.02% of Credential Qtrade Securities's portfolio in Q1 2024, its #217 holding.
  • Credential Qtrade Securities first reported a position in GSK in Q3 2018 and has held it in 23 quarters since.
  • Credential Qtrade Securities's GSK position peaked at $1.28M in Q4 2021.
  • 911 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Credential Qtrade Securities's 13F filing for Q1 2024, filed 21 Jul 2025.